85626-0  Kidney failure 2-year and 5-year risk panel by KFREKidney failure 2-year and 5-year risk panel by KFREKidney failure 2Y & 5Y risk panel: -: Pt: ^Patient: Qn: KFRE  

PANEL HIERARCHY  (view this panel in the LForms viewer)

  LOINC#   LOINC Name R/O/C  Cardinality  Ex. UCUM Units 
  85626-0   Kidney failure 2-year and 5-year risk panel by KFREKidney failure 2-year and 5-year risk panel by KFREKidney failure 2Y & 5Y risk panel: -: Pt: ^Patient: Qn: KFRE    
       85624-5   Kidney failure 2-year risk [Likelihood] by KFREKidney failure 2-year risk [Likelihood] by KFREKidney failure 2Y risk: Likelihood: Pt: ^Patient: Qn: KFRE  
       85625-2   Kidney failure 5-year risk [Likelihood] by KFREKidney failure 5-year risk [Likelihood] by KFREKidney failure 5Y risk: Likelihood: Pt: ^Patient: Qn: KFRE  
       29553-5   Age calculatedAge calculatedAge: Time: Pt: ^Patient: Qn: Calculated  
       46098-0   SexSexSex: Type: Pt: ^Patient: Nom:    
       32294-1   Albumin/​Creatinine [Ratio] in UrineAlbumin/​Creatinine [Ratio] in UrineAlbumin/​Creatinine: Ratio: Pt: Urine: Qn:   mg/mmol{creat} 
       69405-9   Glomerular filtration rate/​1.73 sq M.predicted [Volume Rate/​Area] in Serum, Plasma or BloodGlomerular filtration rate/​1.73 sq M.predicted [Volume Rate/​Area] in Serum, Plasma or BloodGlomerular filtration rate/​1.73 sq M.predicted: ArVRat: Pt: Ser/​Plas/​Bld: Qn:   mL/min 
 

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Kidney failure 2Y & 5Y risk panel  Pt  ^Patient  Qn  KFRE
  Long Common Name:  Kidney failure 2-year and 5-year risk panel by KFRE
  Short Name:  Kidney fail 2Y + 5Y risk KFRE.dyn Pnl
  Display Name:  Kidney failure 2-year and 5-year risk panel KFRE

COPYRIGHT NOTICE
Dr. Navdeep Tangri Copyright notice;

TERM DEFINITION/DESCRIPTION(S)
  The kidney failure risk panel includes terms for reporting the risk of "treated kidney failure" as calculated by the Kidney Failure Risk Equation (KFRE), for patients with chronic kidney disease stages 3 to 5. "Treated kidney failure" is defined as kidney failure that is treated with either dialysis or kidney transplant, and the KFRE includes the following variables: patient age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio (ACR). [PMID: 26757465] This panel includes the terms for two-year risk, five-year risk, and the four variables that are used for the calculation.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.CHEM/Lab
  Panel Type: Panel
  First Released in Version: 2.61
  Last Updated in Version: 2.61
  Order vs. Obs.: Order
  Status: Active

PARTS

Part Type    Part No.  Part Name   
Component   LP248944-3  Kidney failure 2Y & 5Y risk panel   [Kidney failure 2-year and 5-year risk panel] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP248941-9  KFRE   [Kidney Failure Risk Equation] 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肾功能衰竭 2 年与 5 年风险组套:-:时间点:^患者:定量型:肾功能衰竭风险公式肾功能衰竭 2 年与 5 年风险组套:-:时间点:^患者:定量型:肾功能衰竭风险公式
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Kidney failure 2Y & 5Y risk panel:-:Pt:^Patient:Qn:KFREKidney failure 2Y & 5Y risk panel:-:Pt:^Patient:Qn:KFRERisque d'insuffisance rénale 2Y et 5Y [-] Patient ; Numérique ; Facteur de risque insuffisance rénale (KFRE)
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Rischio a 2 & 5 anni di comparsa di insufficienza renale, panel:-:Pt:^Paziente:Qn:KFRERischio a 2 & 5 anni di comparsa di insufficienza renale, panel:-:Pt:^Paziente:Qn:KFRE
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Panel de riesgo en insuficiencia renal a los 2 y 5 años:Propiedades mixtas (sólo paneles):Punto temporal:^paciente:Qn:KFREPanel de riesgo en insuficiencia renal a los 2 y 5 años:Propiedades mixtas (sólo paneles):Punto temporal:^paciente:Qn:KFRE

RELATED NAMES
  Chemistry Panl Quant
  Kidney fail 2Y + 5Y risk Pnl Pnl Quantitative
  Kidney Failure Risk Equation - dynamic Point in time Random
  Pan QNT  
  PANEL.CHEMISTRY Quan  

CHANGE HISTORY
  Change Type: ADD

OBSOLETE FIELDS
  External Copyright Notice: Copyright © Dr. Navdeep Tangri Used with permission

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:28 PM
  Long Common Name: Kidney failure 2-year and 5-year risk panel by KFRE
  Shortname: Kidney fail 2Y + 5Y risk KFRE.dyn Pnl
  Fully Specified Name: Kidney failure 2Y & 5Y risk panel: -: Pt: ^Patient: Qn: KFRE
     
  Component Word Count: 6
  ID: 91091
  # of Panel Elements: 7
  Status (Raw): ACTIVE



Selected information about each LOINC that is part of this panel



85624-5   Kidney failure 2-year risk [Likelihood] by KFREKidney failure 2-year risk [Likelihood] by KFREKidney failure 2Y risk: Likelihood: Pt: ^Patient: Qn: KFRE  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Kidney failure 2Y risk  Likelihood  Pt  ^Patient  Qn  KFRE
  Long Common Name:  Kidney failure 2-year risk [Likelihood] by KFRE
  Short Name:  Kidney fail 2Y risk KFRE.dynamic
  Display Name:  Kidney failure 2-year risk KFRE Qn

TERM DEFINITION/DESCRIPTION(S)
  The two-year "treated kidney failure" risk as calculated by the Kidney Failure Risk Equation (KFRE), for patients with chronic kidney disease stages 3 to 5. "Treated kidney failure" is defined as kidney failure that is treated with either dialysis or kidney transplant. The KFRE includes the following variables: patient age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio (ACR). In this model, all variables are time-independent, in that the baseline measurement is used for all calculations. [PMID: 26757465]
 
 

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 2.61
  Last Updated in Version: 2.64
  Order vs. Obs.: Both
  Status: Active.
Change Reason: Corrected log to natural log (ln) in the formula.

FORMULA -- READABLE
1 - 0.9750 ^ exp (-0.2201 × (age/10 - 7.036) + 0.2467 × (male - 0.5642) - 0.5567 × (eGFR/5 - 7.222) + 0.4510 × (lnACR - 5.137)); male is valued as 1 if patient is male, and 0 if patient is female

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  

PARTS

Part Type    Part No.  Part Name   
Component   LP248942-7  Kidney failure 2Y risk   [Kidney failure 2-year risk] 
Property   LP185777-2  Likelihood 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP248941-9  KFRE   [Kidney Failure Risk Equation] 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肾功能衰竭 2 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式肾功能衰竭 2 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Kidney failure 2Y risk:Likelihood:Pt:^Patient:Qn:KFREKidney failure 2Y risk:Likelihood:Pt:^Patient:Qn:KFRERisque d'insuffisance rénale calculé sur 2 ans [Probabilité] Patient ; Numérique ; Facteur de risque insuffisance rénale (KFRE)
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Rischio a 2 anni di comparsa di insufficienza renale:Probabilità:Pt:^Paziente:Qn:KFRERischio a 2 anni di comparsa di insufficienza renale:Probabilità:Pt:^Paziente:Qn:KFRE
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Riesgo de insuficiencia renal en 2 años:Probabilidad:Punto temporal:^paciente:Qn:KFRERiesgo de insuficiencia renal en 2 años:Probabilidad:Punto temporal:^paciente:Qn:KFRE

RELATED NAMES
  Chemistry QNT Random
  Kidney fail 2Y risk Quan Risk
  Kidney Failure Risk Equation - dynamic Quant  
  Point in time Quantitative  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

CHANGE HISTORY
  Change Type: MIN

OBSOLETE FIELDS
  External Copyright Notice: Copyright © Dr. Navdeep Tangri Used with permission

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:28 PM
  Long Common Name: Kidney failure 2-year risk [Likelihood] by KFRE
  Shortname: Kidney fail 2Y risk KFRE.dynamic
  Fully Specified Name: Kidney failure 2Y risk: Likelihood: Pt: ^Patient: Qn: KFRE
     
  Component Word Count: 4
  ID: 91089
  Status (Raw): ACTIVE


85625-2   Kidney failure 5-year risk [Likelihood] by KFREKidney failure 5-year risk [Likelihood] by KFREKidney failure 5Y risk: Likelihood: Pt: ^Patient: Qn: KFRE  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Kidney failure 5Y risk  Likelihood  Pt  ^Patient  Qn  KFRE
  Long Common Name:  Kidney failure 5-year risk [Likelihood] by KFRE
  Short Name:  Kidney fail 5Y risk KFRE.dynamic
  Display Name:  Kidney failure 5-year risk KFRE Qn

TERM DEFINITION/DESCRIPTION(S)
  The five-year "treated kidney failure" risk as calculated by the Kidney Failure Risk Equation (KFRE), for patients with chronic kidney disease stages 3 to 5. "Treated kidney failure" is defined as kidney failure that is treated with either dialysis or kidney transplant. The KFRE includes the following variables: patient age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio (ACR). In this model, all variables are time-independent, in that the baseline measurement is used for all calculations. [PMID: 26757465]
 
 

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 2.61
  Last Updated in Version: 2.64
  Order vs. Obs.: Both
  Status: Active.
Change Reason: Corrected log to natural log (ln) in the formula.

FORMULA -- READABLE
1 - 0.9240 ^ exp (-0.2201 × (age/10 - 7.036) + 0.2467 × (male - 0.5642) - 0.5567 × (eGFR/5 - 7.222) + 0.4510 × (lnACR - 5.137)); ; male is valued as 1 if patient is male, and 0 if patient is female

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  

PARTS

Part Type    Part No.  Part Name   
Component   LP248943-5  Kidney failure 5Y risk   [Kidney failure 5-year risk] 
Property   LP185777-2  Likelihood 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP248941-9  KFRE   [Kidney Failure Risk Equation] 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肾功能衰竭 5 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式肾功能衰竭 5 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Kidney failure 5Y risk:Likelihood:Pt:^Patient:Qn:KFREKidney failure 5Y risk:Likelihood:Pt:^Patient:Qn:KFRERisque d'insuffisance rénale calculé sur 5 ans [Probabilité] Patient ; Numérique ; Facteur de risque insuffisance rénale (KFRE)
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Rischio a 5 anni di comparsa di insufficienza renale:Probabilità:Pt:^Paziente:Qn:KFRERischio a 5 anni di comparsa di insufficienza renale:Probabilità:Pt:^Paziente:Qn:KFRE
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Riesgo de insuficiencia renal en 5 años:Probabilidad:Punto temporal:^paciente:Qn:KFRERiesgo de insuficiencia renal en 5 años:Probabilidad:Punto temporal:^paciente:Qn:KFRE

RELATED NAMES
  Chemistry QNT Random
  Kidney fail 5Y risk Quan Risk
  Kidney Failure Risk Equation - dynamic Quant  
  Point in time Quantitative  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

CHANGE HISTORY
  Change Type: MIN

OBSOLETE FIELDS
  External Copyright Notice: Copyright © Dr. Navdeep Tangri Used with permission

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:28 PM
  Long Common Name: Kidney failure 5-year risk [Likelihood] by KFRE
  Shortname: Kidney fail 5Y risk KFRE.dynamic
  Fully Specified Name: Kidney failure 5Y risk: Likelihood: Pt: ^Patient: Qn: KFRE
     
  Component Word Count: 4
  ID: 91090
  Status (Raw): ACTIVE


29553-5   Age calculatedAge calculatedAge: Time: Pt: ^Patient: Qn: Calculated  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Age  Time  Pt  ^Patient  Qn  Calculated
  Long Common Name:  Age calculated
  Short Name:  Age Time Patient Calc
  Display Name:  Age Calc [Time]

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  First Released in Version: 2.03
  Last Updated in Version: 2.40
  Order vs. Obs.: Observation
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  

PARTS

Part Type    Part No.  Part Name   
Component   LP28815-6  Age 
Property   LP6879-3  Time   [Time (e.g. seconds)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP6165-7  Calculated 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  年龄:时间:时间点:^患者:定量型:计算法年龄:时间:时间点:^患者:定量型:计算法
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  leeftijd:tijd:moment:^patiënt:kwantitatief:berekendleeftijd:tijd:moment:^patiënt:kwantitatief:berekend
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Vanus:Aeg:Pt:^patsient:Qn:ArvutuslikVanus:Aeg:Pt:^patsient:Qn:Arvutuslik
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Âge:Durée:Temps ponctuel:^Patient:Quantitatif:CalculéÂge:Durée:Temps ponctuel:^Patient:Quantitatif:Calculé
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Âge:Durée:Temps ponctuel:^Patient:Quantitatif:CalculéÂge:Durée:Temps ponctuel:^Patient:Quantitatif:Calculé
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Age:Time:Pt:^Patient:Qn:CalculatedAge:Time:Pt:^Patient:Qn:CalculatedÂge [Temps] Patient ; Numérique ; Résultat calculé
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Alter:Zeit:Pkt:^Patient:Qn:ErrechnetAlter:Zeit:Pkt:^Patient:Qn:Errechnet
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Età:Tempo:Pt:^Paziente:Qn:CalcolatoEtà:Tempo:Pt:^Paziente:Qn:Calcolato
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Idade:Tempo:Pt:^Paciente:Qn:CalculadoIdade:Tempo:Pt:^Paciente:Qn:Calculado
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Возраст:Время:ТчкВрм:^Пациент:Колич:ВычисленныйВозраст:Время:ТчкВрм:^Пациент:Колич:Вычисленный
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  edad:tiempo:punto en el tiempo:^paciente:cuantitativo:calculadoedad:tiempo:punto en el tiempo:^paciente:cuantitativo:calculado
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Edad:Tiempo:Punto temporal:^paciente:Qn:CalculadoEdad:Tiempo:Punto temporal:^paciente:Qn:Calculado
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Yaş:Süre:Zmlı:^Hasta:Kant:HesaplanmışYaş:Süre:Zmlı:^Hasta:Kant:Hesaplanmış

RELATED NAMES
  Calc Point in time Quant
  Calculation QNT Quantitative
  MISC Quan Random

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:28 PM
  Attachment Units Required: N
  Long Common Name: Age calculated
  Shortname: Age Time Patient Calc
  Fully Specified Name: Age: Time: Pt: ^Patient: Qn: Calculated
     
  Component Word Count: 1
  ID: 21334
  Status (Raw): ACTIVE


46098-0   SexSexSex: Type: Pt: ^Patient: Nom:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Sex  Type  Pt  ^Patient  Nom 
  Long Common Name:  Sex
  Short Name:  Sex

PART DEFINITION/DESCRIPTION(S)
  Part: Sex
  In LOINC, sex refers to the biological sex of an organism, which is most commonly determined based on anatomy and physiology or genetic (chromosome) analysis. Our definition is based on the World Health Organization's definition of sex and gender: sex (male, female) refers to biological and physiological characteristics, and gender (masculine, feminine) refers to socially constructed roles, behaviors, activities, and attributes. (http://www.who.int/gender/whatisgender/en)
 
 

BASIC ATTRIBUTES
  Class/Type: ADMIN.PATIENT.DEMOG/Clinical
  First Released in Version: 2.17
  Last Updated in Version: 2.66
  Order vs. Obs.: Both
  Status: Active.
Change Reason: Changed Component from 'Gender' to 'Sex' to align with the World Health Organization (WHO) definition of this concept.

HL7 ATTRIBUTES
  HL7 Field ID: PID-8

EXAMPLE ANSWER LIST    (LL1-9)  
 
Source: Regenstrief LOINC
  SEQ#        Answer        Code         Answer ID    
  1       Male       1       LA2-8  
  2       Female       2       LA3-6  

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code and, if applicable, override LOINC answer lists that are associated with this LOINC term in the context of that panel. Override lists are used when the panel requires a different answer list and/or answer list link type than the default answer list associated with this LOINC.
  LOINC   Long Common Name   Answer List Id Answer List Type   # of answers
  45963-6 MDS basic assessment tracking form - version 2.0
  46462-8 Outcome and assessment information set (OASIS) form - version B1
  47245-6 HIV treatment form Document
  52743-2 Continuity Assessment Record and Evaluation (CARE) tool - Acute Care
  52744-0 Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Admission
  52745-7 Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Discharge
  52746-5 Continuity Assessment Record and Evaluation (CARE) tool - Interim
  52747-3 Continuity Assessment Record and Evaluation (CARE) tool - Expired
  52748-1 Continuity Assessment Record and Evaluation (CARE) tool - Home Health Admission
  54580-6 Minimum Data Set - version 3.0
  55140-8 Vaccine Adverse Event Reporting System (VAERS) panel
  55168-9 Data Elements for Emergency Department Systems (DEEDS) Release 1.1
  57039-0 Outcome and assessment information set (OASIS) form - version C
  57190-1 Outcome and assessment information set (OASIS) form - version C - Start of care
  61129-3 PhenX domain - Demographics
  62263-9 PhenX domain - Nutrition and dietary supplements
  62611-9 PhenX domain - Respiratory
  62755-4 PhenX domain - Neurology
  62787-7 PhenX domain - Diabetes
  62812-3 PhenX domain - Physical activity and physical fitness
  62863-6 PhenX domain - Infectious diseases and immunity
  63009-5 PhenX domain - Social environments
  63067-3 PhenX domain - Speech and hearing
  67868-0 End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728
  68359-9 End Stage Renal Disease (ESRD) Death Notification - OMB CMS form 2746
  69412-5 Continuity Assessment Record and Evaluation (CARE) tool - Long term care hospital (LTCH) - version 1.0
  69723-5 Patient Health Questionnaire (PHQ) [Reported]
  69919-9 Race, ethnicity, sex, primary language, disability - Health and Human Services (HHS) panel [HHS.ACA Section 4302]
  70297-7 ESRD patient information panel
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  78699-6 Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
  82259-3 Metabolic equivalent of task and Resting metabolic rate panel
  82287-4 Physical activity panel
  83265-9 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.4 [CMS Assessment]
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  85645-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 [CMS Assessment]
  85662-5 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00 [CMS Assessment]
  85668-2 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00 [CMS Assessment]
  85671-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00 [CMS Assessment]
  85907-4 Outcome and assessment information set (OASIS) form - version C2 - Start of care [CMS Assessment]
  86522-0 MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  86636-8 Family planning report - FPAR 2.0 set
  86856-2 MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) and Nursing home quarterly (NQ) item set [CMS Assessment]
  86870-3 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA (NO/SO) item set [CMS Assessment]
  86871-1 MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  86872-9 MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  86873-7 MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  86874-5 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA start of therapy (NS/SS) item set [CMS Assessment]
  86875-2 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed tracking (NT/ST) item set [CMS Assessment]
  86876-0 MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set [CMS Assessment]
  86877-8 MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  87414-9 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment]
  87506-2 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 [CMS Assessment]
  87507-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 [CMS Assessment]
  87508-8 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 [CMS Assessment]
  87509-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 [CMS Assessment]
  88279-5 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment]
  88280-3 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment]
  88281-1 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  88282-9 MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  88283-7 MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  88284-5 MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  88285-2 MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  88286-0 MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  88287-8 MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set [CMS Assessment]
  88288-6 MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set [CMS Assessment]
  88292-8 MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  88329-8 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 2.0 [CMS Assessment]
  88373-6 Outcome and assessment information set (OASIS) form - version D - Start of care [CMS Assessment]
  88945-1 MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  88946-9 MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  88947-7 MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  88948-5 MDS v3.0 - RAI v1.16.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  88949-3 MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set [CMS Assessment]
  88950-1 MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set [CMS Assessment]
  88951-9 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment]
  88952-7 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment]
  88953-5 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  88954-3 MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  88955-0 MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  89070-7 ADAPTABLE patient reported item set [ADAPTABLE]
  89724-9 Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers]
  89963-3 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 3.0 [CMS Assessment] LL1-9 NORMATIVE 2
  90473-0 MDS v3.0 - RAI v1.17.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  90474-8 MDS v3.0 - RAI v1.17.1 - Nursing home PPS (NP) item set [CMS Assessment]
  90475-5 MDS v3.0 - RAI v1.17.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  90476-3 MDS v3.0 - RAI v1.17.1 - Swing bed PPS (SP) item set [CMS Assessment]
  90477-1 MDS v3.0 - RAI v1.17.1 - Nursing home discharge (ND) item set [CMS Assessment]
  90478-9 MDS v3.0 - RAI v1.17.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  90479-7 MDS v3.0 - RAI v1.17.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  90480-5 MDS v3.0 - RAI v1.17.1 - Interim Payment Assessment (IPA) item set [CMS Assessment]
  90481-3 MDS v3.0 - RAI v1.17.1 - Optional State Assessment (OSA) item set [CMS Assessment]
  91393-9 Opioid risk tool panel
  91552-0 MDS v3.0 - RAI v1.17.1 - Swing bed discharge (SD) item set [CMS Assessment]
  

PARTS

Part Type    Part No.  Part Name   
Component   LP101395-4  Sex 
Property   LP6886-8  Type 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP345158-2  Sex 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  性别:类型:时间点:^患者:名义型:性别:类型:时间点:^患者:名义型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  geslacht:type:moment:^patiënt:nominaal:geslacht:type:moment:^patiënt:nominaal:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Sugu:Tüüp:Pt:^patsient:Nom:Sugu:Tüüp:Pt:^patsient:Nom:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Sexe:Type:Temps ponctuel:^Patient:Nominal:Sexe:Type:Temps ponctuel:^Patient:Nominal:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Sexe:Type:Temps ponctuel:^Patient:Nominal:Sexe:Type:Temps ponctuel:^Patient:Nominal:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Sesso:Tipo:Pt:^Paziente:Nom:Sesso:Tipo:Pt:^Paziente:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Пол:Тип:ТчкВрм:^Пациент:Ном:Пол:Тип:ТчкВрм:^Пациент:Ном:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Sexo:Tipo:Punto temporal:^paciente:Nom:Sexo:Tipo:Punto temporal:^paciente:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Cinsiyet:Tip:Zmlı:^Hasta:Snf:Cinsiyet:Tip:Zmlı:^Hasta:Snf:

RELATED NAMES
  ADMIN Gender Random
  ADMIN.PATIENT Nominal Typ
  ADMIN.PT.DEMOG Point in time  

RELATED CODES
Code System Code Code Text Code Version
   CMS IRF-PAI   8     3.0 
   CMS IRF-PAI   8     1.4 
   CMS IRF-PAI   8     1.5 
   CMS IRF-PAI   8     2.0 
   CMS LCDS   A0800     4.00 
   CMS LCDS   A0800     3.00 
   CMS MDS   A0800     1.16.1 
   CMS MDS   A0800     1.15.1 
   CMS MDS   A0800     1.17.1 
   CMS MDS   A0800     1.14.1 
   CMS MDS   X0300     1.17.1 
   CMS MDS   X0300     1.14.1 
   CMS MDS   X0300     1.16.1 
   CMS MDS   X0300     1.15.1 
   CMS OASIS   M0069     C2 
   CMS OASIS   M0069     D 
   https://www.phenxtoolkit.org   PX070601010100   PX070601_Self_Gender   
   https://www.phenxtoolkit.org   PX091501010400   PX091501_Sleep_Apnea_Gender   
   https://www.phenxtoolkit.org   PX091502040000   PX091502_Child_Gender   
   https://www.phenxtoolkit.org   PX091601390000   PX091601_Sex   
   https://www.phenxtoolkit.org   PX130501020200   PX130501_Gender   
   https://www.phenxtoolkit.org   PX140201010100   PX140201_Spouse_Sex   
   https://www.phenxtoolkit.org   PX150101020000   PX150101_Sex   
   https://www.phenxtoolkit.org   PX150102010000   PX150102_Sex   
   https://www.phenxtoolkit.org   PX150201020000   PX150201_Gender   
   https://www.phenxtoolkit.org   PX150202020000   PX150202_Gender   
   https://www.phenxtoolkit.org   PX150203010000   PX150203_Gender   
   https://www.phenxtoolkit.org   PX161201010000   PX161201_Gender   
   https://www.phenxtoolkit.org   PX201501170101   PX201501_Sibling1_Sex   
   https://www.phenxtoolkit.org   PX201501170104   PX201501_Sibling1_Cause_Of_Hearing_Difficulty   
   https://www.phenxtoolkit.org   PX201501170203   PX201501_Sibling2_Age_Onset_Hearing_Difficulty   
   https://www.phenxtoolkit.org   PX201501170302   PX201501_Sibling3_Birth_Year   
   https://www.phenxtoolkit.org   PX201501170401   PX201501_Sibling4_Sex   
   https://www.phenxtoolkit.org   PX211101010400   PX211101_Person1_Gender   
   https://www.phenxtoolkit.org   PX211101020400   PX211101_Person2_Gender   
   https://www.phenxtoolkit.org   PX211101030400   PX211101_Person3_Gender   
   https://www.phenxtoolkit.org   PX211101040400   PX211101_Person4_Gender   
   https://www.phenxtoolkit.org   PX211101050400   PX211101_Person5_Gender   
   https://www.phenxtoolkit.org   PX211101060400   PX211101_Person6_Gender   
   https://www.phenxtoolkit.org   PX211101070400   PX211101_Person7_Gender   
   https://www.phenxtoolkit.org   PX211101080400   PX211101_Person8_Gender   
   https://www.phenxtoolkit.org   PX211101090400   PX211101_Person9_Gender   
   https://www.phenxtoolkit.org   PX211101100400   PX211101_Person10_Gender   
   https://www.phenxtoolkit.org   PX211101110400   PX211101_Person11_Gender   
   https://www.phenxtoolkit.org   PX211101120400   PX211101_Person12_Gender   
   https://www.phenxtoolkit.org   PX211101130400   PX211101_Person13_Gender   
   https://www.phenxtoolkit.org   PX211101140400   PX211101_Person14_Gender   
   https://www.phenxtoolkit.org   PX211101150400   PX211101_Person15_Gender   
   https://www.phenxtoolkit.org   PX211101160400   PX211101_Person16_Gender   
   https://www.phenxtoolkit.org   PX211101170400   PX211101_Person17_Gender   
   https://www.phenxtoolkit.org   PX211101180400   PX211101_Person18_Gender   
   https://www.phenxtoolkit.org   PX211101190400   PX211101_Person19_Gender   
   https://www.phenxtoolkit.org   PX211101200400   PX211101_Person20_Gender   

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:28 PM
  Attachment Units Required: N
  Long Common Name: Sex
  Shortname: Sex
  Fully Specified Name: Sex: Type: Pt: ^Patient: Nom:
     
  Component Word Count: 1
  ID: 39502
  Status (Raw): ACTIVE


32294-1   Albumin/​Creatinine [Ratio] in UrineAlbumin/​Creatinine [Ratio] in UrineAlbumin/​Creatinine: Ratio: Pt: Urine: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Albumin/Creatinine  Ratio  Pt  Urine  Qn 
  Long Common Name:  Albumin/Creatinine [Ratio] in Urine
  Short Name:  Albumin/Creat Ur-Rto
  Display Name:  Albumin/Creatinine (U) [Ratio]

PART DEFINITION/DESCRIPTION(S)
  Part: Albumin
  A non-glycosylated protein that is synthesized in the liver parenchymal cells, regulated by colloid osmotic pressure from interstitial fluid surrounding hepatocytes, and catabolized in nearly all organs. Albumin comprises >50% of plasma proteins in plasma, CSF and urine, and therefore is a key contributor to intravascular oncotic pressure and regulating fluid concentration in tissues. Albumin also binds and transports a variety of endogenous substances and medications. Serum albumin measurement is a reflection of hydration and nutritional status, blood oncotic pressure, liver and kidney function, and other chronic diseases, and the ratio of albumin in the CSF and serum can be used to evaluate blood brain barrier disorders. [Tietz] Urine albumin of less than 30 mg/day is considered normal. Microalbuminuria is defined as urine albumin of 30-300 mg/day and is an early sign of kidney damage from disorders such as diabetes or hypertension. Albuminuria is urine albumin >300 mg/day and is associated with overt kidney disease. [PMID: 25512779]
 
 

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 2.07
  Last Updated in Version: 2.42
  Order vs. Obs.: Both
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: mg/mmol

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  54037-7 HEDIS 2009 panel
  57820-3 HEDIS 2010 panel
  60442-1 HEDIS 2011 panel
  67767-4 HEDIS 2012 panel
  72199-3 HEDIS 2013 panel
  74234-6 HEDIS 2014 Value Sets
  75868-0 HEDIS 2015 Value Sets
  79544-3 HEDIS 2016 Value Sets
  82955-6 HEDIS 2017 Value Sets
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  87625-0 HEDIS 2018 Value Sets
  90766-7 HEDIS 2019 Value Sets
  

MEMBER OF THESE EQUIVALENCE GROUPS
  LG11837-8  Albumin/Creatinine|Ratio|Pt|ANYUrine
  LG35830-5  Albumin/Creatinine|Ratio|Urine

PARTS

Part Type    Part No.  Part Name   
Component   LP6118-6  Albumin 
     Divisors   LP32035-5  Creatinine 
Property   LP6852-0  Ratio 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7681-2  Urine 
Scale   LP7753-9  Qn 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  白蛋白/​肌酐:比率:时间点:尿液:定量型:白蛋白/​肌酐:比率:时间点:尿液:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  albumine/​creatinine:verhouding:moment:urine:kwantitatief:albumine/​creatinine:verhouding:moment:urine:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Albumiin/​kreatiniin:Suhe:Pt:U:Qn:Albumiin/​kreatiniin:Suhe:Pt:U:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Albumine/​Créatinine:Ratios:Temps ponctuel:Urine:Quantitatif:Albumine/​Créatinine:Ratios:Temps ponctuel:Urine:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Albumine/​Créatinine:Ratios:Temps ponctuel:Urine:Quantitatif:Albumine/​Créatinine:Ratios:Temps ponctuel:Urine:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Albumin/​Creatinine:Ratio:Pt:Urine:Qn:Albumin/​Creatinine:Ratio:Pt:Urine:Qn:Albumine/​créatinine [Ratio] Urine ; Numérique
  French (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  U--albumine; rapport à la créatinine
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Albumin/​Kreatinin:Ratio:Pkt:Urin:Qn:Albumin/​Kreatinin:Ratio:Pkt:Urin:Qn:
  German (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  U--Albumin; Ratio zu Kreatinin
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Albumina/​Creatinina:Rapporto:Pt:Urine:Qn:Albumina/​Creatinina:Rapporto:Pt:Urine:Qn:
  Italian (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  U--albumina; rapporto alla creatinina
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  알부민/​크레아티닌:비율:검사시점:뇨:정량:알부민/​크레아티닌:비율:검사시점:뇨:정량:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Albumina/​Creatinina:Ratio:Pt:Urina:Qn:Albumina/​Creatinina:Ratio:Pt:Urina:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Альбумин/​Креатинин:Отношение:ТчкВрм:Моча:Колич:Альбумин/​Креатинин:Отношение:ТчкВрм:Моча:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  albúmina/​creatinina:relación:punto en el tiempo:orina:cuantitativo:albúmina/​creatinina:relación:punto en el tiempo:orina:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Albúmina/​Creatinina:Fracción:Punto temporal:Orina:Qn:Albúmina/​Creatinina:Fracción:Punto temporal:Orina:Qn:
  Spanish (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  O--albumina; relación a la creatinina
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Albumin/​Kreatinin:Oran:Zmlı:İdrar:Kant:Albumin/​Kreatinin:Oran:Zmlı:İdrar:Kant:

RELATED NAMES
  Alb QNT UA
  Chemistry Quan UCr
  CR Quant UR
  Crea Quantitative Urn
  Creat Random  
  Point in time Ratios  
  Protein.albumin Rto  

EXAMPLE UNITS
  Unit  Source Type
  mg/mmol  ORIGINAL SUBMISSION 
  mg/mmol  eCHN 
  mg/mmol{creat}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  mg/mmol 
  Source Type:  eCHN 
  Unit:  mg/mmol 
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  mg/mmol{creat} 

CHANGE HISTORY
  Change Type: MIN

ARTICLE
  Description: Laboratory Measurement of Urine Albumin and Urine Total Protein in Screening for Proteinuria in Chronic Kidney Disease
 
 

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:29 PM
  Attachment Units Required: N
  Long Common Name: Albumin/Creatinine [Ratio] in Urine
  Shortname: Albumin/Creat Ur-Rto
  Fully Specified Name: Albumin/Creatinine: Ratio: Pt: Urine: Qn:
     
  Component Word Count: 2
  ID: 24385
  Status (Raw): ACTIVE


69405-9   Glomerular filtration rate/​1.73 sq M.predicted [Volume Rate/​Area] in Serum, Plasma or BloodGlomerular filtration rate/​1.73 sq M.predicted [Volume Rate/​Area] in Serum, Plasma or BloodGlomerular filtration rate/​1.73 sq M.predicted: ArVRat: Pt: Ser/​Plas/​Bld: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Glomerular filtration rate/1.73 sq M.predicted  ArVRat  Pt  Ser/Plas/Bld  Qn 
  Long Common Name:  Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
  Short Name:  GFR/BSA.pred SerPlBld-ArVRat
  Display Name:  GFR/1.73 sq M.predicted (S/P/Bld) [Vol rate/Area]

TERM DEFINITION/DESCRIPTION(S)
  The Glomerular Filtration Rate is a system generated value calculated from the selected GFR lab method
 
 

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.64
  Order vs. Obs.: Both
  Status: Active.
Change Reason: System changed from "Ser/Plas" to "Ser/Plas/Bld". According to the National Kidney Disease Education Program (NKDEP) Lab Working Group, estimated GFR may be calculated based on blood, serum, or plasma creatinine levels. Whole blood methods are calibrated to be the same as serum/plasma methods, and the isotope dilution mass spectrometry (IDMS) reference measurement procedure is the same for whole blood, serum, and plasma.

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  

PARTS

Part Type    Part No.  Part Name   
Component   LP69203-5  Glomerular filtration rate 
     Divisors   LP69197-9  1.73 sq M.predicted 
Property   LP6787-8  ArVRat   [Volume Rate/Area] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7579-8  Ser/Plas/Bld   [Serum, Plasma or Blood] 
Scale   LP7753-9  Qn 
Fragments for synonyms   LP20709-9  Sq M 
Fragments for synonyms   LP20770-1  Glomerular 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肾小球滤过率/​1.73 平方米.预测型:单位面积体积速率:时间点:血清/​血浆/​全血:定量型:肾小球滤过率/​1.73 平方米.预测型:单位面积体积速率:时间点:血清/​血浆/​全血:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  glomerulaire filtratie snelheid/​1,73 m2.voorspeld:filtratiesnelheid/​oppervlakte:moment:serum of plasma of bloed:kwantitatief:glomerulaire filtratie snelheid/​1,73 m2.voorspeld:filtratiesnelheid/​oppervlakte:moment:serum of plasma of bloed:kwantitatief:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Taux de filtration glomérulaire/​1,73m surface , valeur prédite:Taux de volume de l'aire:Temps ponctuel:Sérum/​Plasma/​Sang:Quantitatif:Taux de filtration glomérulaire/​1,73m surface , valeur prédite:Taux de volume de l'aire:Temps ponctuel:Sérum/​Plasma/​Sang:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Taux de filtration glomérulaire/​1,73m ca, valeur prédite:Taux de volume de l'aire:Temps ponctuel:Sérum/​Plasma/​Sang:Quantitatif:Taux de filtration glomérulaire/​1,73m ca, valeur prédite:Taux de volume de l'aire:Temps ponctuel:Sérum/​Plasma/​Sang:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Glomerular filtration rate/​1.73 sq M.predicted:ArVRat:Pt:Ser/​Plas/​Bld:Qn:Glomerular filtration rate/​1.73 sq M.predicted:ArVRat:Pt:Ser/​Plas/​Bld:Qn:Filtration glomérulaire corrigée/​1,73m2 calculée [Volume arbitraire/​Temps] Sérum/​Plasma/​Sang ; Numérique
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Tasso di filtrazione glomerulare/​1,73 m2.previsto:ArVRat:Pt:Siero/​Plasma/​Sangue:Qn:Tasso di filtrazione glomerulare/​1,73 m2.previsto:ArVRat:Pt:Siero/​Plasma/​Sangue:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Клубочковой фильтрации скорость/​1,73 кв м.прогнозный:ПлощадьОбСкор:ТчкВрм:Сыв/​Плаз/​Кр:Колич:Клубочковой фильтрации скорость/​1,73 кв м.прогнозный:ПлощадьОбСкор:ТчкВрм:Сыв/​Плаз/​Кр:Колич:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Tasa de filtración glomerular/​1,73 metros cuadrados previsto:Indice de Volumen/​Área:Punto temporal:Suero, Plasma o Sangre:Qn:Tasa de filtración glomerular/​1,73 metros cuadrados previsto:Indice de Volumen/​Área:Punto temporal:Suero, Plasma o Sangre:Qn:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Glomerülar filtrasyon hızı/​1.73 M kare.öngörülen:AlanVHz:Zmlı:Ser/​Plaz/​Kan:Kant:Glomerülar filtrasyon hızı/​1.73 M kare.öngörülen:AlanVHz:Zmlı:Ser/​Plaz/​Kan:Kant:

RELATED NAMES
  Blood Plsm SerPlBld
  BSA.pred Point in time Serum
  Chemistry Pred GFR Serum or plasma
  EGFR QNT Serum, plasma or whole blood
  Estimated GFR Quan Square Meter
  GFR Quant SR
  GFR/1.73 sq M Quantitative Volume rate/area
  Glom Random Volume Rate/Ratio
  Pl SerP WB
  PlasBld SerPl Whole blood
  Plasma SerPlas  

EXAMPLE UNITS
  Unit  Source Type
  mL/min  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  mL/min 

CHANGE HISTORY
  Change Type: MAJ

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 1:43:29 PM
  Attachment Units Required: N
  Long Common Name: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
  Shortname: GFR/BSA.pred SerPlBld-ArVRat
  Fully Specified Name: Glomerular filtration rate/1.73 sq M.predicted: ArVRat: Pt: Ser/Plas/Bld: Qn:
     
  Component Word Count: 7
  ID: 68716
  Status (Raw): ACTIVE

COPYRIGHT
  Organization:Dr. Navdeep Tangri
  Copyright:Copyright © Dr. Navdeep Tangri
  Terms of Use:Used with permission
  URL:http://kidneyfailurerisk.com/